Waypoint Capital Advisors, LLC Oncternal Therapeutics, Inc. Transaction History

Waypoint Capital Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	SELL	$0.29 - $0.48 $3,479 - $5,759	-11,998 Reduced 31.35%	26,271 $7,000
Q4 2022 Jan 23, 2023	BUY	$0.86 - $22.2 $32,911 - $849,571	38,269 New	38,269 $0
Q2 2022 Jul 18, 2022	SELL	$0.7 - $1.56 $31,062 - $69,225	-44,375 Closed	0 $0
Q1 2022 Apr 19, 2022	BUY	$1.37 - $2.43 $60,793 - $107,831	44,375 New	44,375 $52,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Waypoint Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Waypoint Capital Advisors, LLC with notifications on news.